Farhad Hafezi, Popular press Cross-Linking in children: distinct early improvement at 12 weeks after CXL CXL for progressive keratoconus in a 12-year-old boy from San Francisco that came to ELZA for treatment by Prof. Farhad Hafezi June 17, 2015 Read More
Farhad Hafezi, Popular press Cross-Linking in children: distinct early improvement at 12 weeks after CXL CXL for progressive keratoconus in a 12-year-old boy from San Francisco that came to ELZA for treatment by Prof. Farhad Hafezi June 17, 2015 Read More
Nikki Hafezi, Popular press Enterprising Ophthalmology How to enterprise ophthalmology: 3 parties, 3 countries, 3 approaches, with the ELZA Institute by Prof. Farhad Hafezi June 11, 2015 Read More
Nikki Hafezi, Popular press Enterprising Ophthalmology How to enterprise ophthalmology: 3 parties, 3 countries, 3 approaches, with the ELZA Institute by Prof. Farhad Hafezi June 11, 2015 Read More
Nikki Hafezi, Popular press You Have a Great Idea. Now What? Nikki Hafezi gives a guide to turning bright ideas into commercial realities by Prof. Farhad Hafezi January 23, 2015 Read More
Nikki Hafezi, Popular press You Have a Great Idea. Now What? Nikki Hafezi gives a guide to turning bright ideas into commercial realities by Prof. Farhad Hafezi January 23, 2015 Read More
Farhad Hafezi, Popular press Cross-Linking thin corneas Specialists intrigued by new approaches to cross-linking thin corneas. by Prof. Farhad Hafezi January 15, 2015 Read More
Farhad Hafezi, Popular press Cross-Linking thin corneas Specialists intrigued by new approaches to cross-linking thin corneas. by Prof. Farhad Hafezi January 15, 2015 Read More
Farhad Hafezi, Popular press Accelerating PACK-CXL Increasing the intensity of illumination degrades the efficacy of regular CXL, but it doesn’t seem to with PACK- CXL by Prof. Farhad Hafezi January 10, 2015 Read More
Farhad Hafezi, Popular press Accelerating PACK-CXL Increasing the intensity of illumination degrades the efficacy of regular CXL, but it doesn’t seem to with PACK- CXL by Prof. Farhad Hafezi January 10, 2015 Read More
Farhad Hafezi, Popular press New therapy for Terrien’s Marginal Degeneration “We only treated two eyes, but it was the first time a Terrien could be stopped and partially reversed,” Farhad Hafezi, MD, PhD, OSN Europe Edition Board Member, said in a telephone interview with Ocular Surgery News by Prof. Farhad Hafezi November 1, 2014 Read More
Farhad Hafezi, Popular press New therapy for Terrien’s Marginal Degeneration “We only treated two eyes, but it was the first time a Terrien could be stopped and partially reversed,” Farhad Hafezi, MD, PhD, OSN Europe Edition Board Member, said in a telephone interview with Ocular Surgery News by Prof. Farhad Hafezi November 1, 2014 Read More
Farhad Hafezi, Popular press Major award to swiss eye surgeon and researcher by Prof. Farhad Hafezi October 17, 2014 Read More
Farhad Hafezi, Popular press Major award to swiss eye surgeon and researcher by Prof. Farhad Hafezi October 17, 2014 Read More
Farhad Hafezi, Popular press Casebeer Award 2014 to Swiss Ophthalmologist by Prof. Farhad Hafezi October 12, 2014 Read More
Farhad Hafezi, Popular press Casebeer Award 2014 to Swiss Ophthalmologist by Prof. Farhad Hafezi October 12, 2014 Read More
Farhad Hafezi, Popular press Casebeer Award 2014 of the ISRS at the AAO by Prof. Farhad Hafezi October 8, 2014 Read More
Farhad Hafezi, Popular press Casebeer Award 2014 of the ISRS at the AAO by Prof. Farhad Hafezi October 8, 2014 Read More
Farhad Hafezi, Popular press Swiss ophthalmologist receives US award by Prof. Farhad Hafezi October 4, 2014 Read More
Farhad Hafezi, Popular press Swiss ophthalmologist receives US award by Prof. Farhad Hafezi October 4, 2014 Read More
